Navigation

Diabetic retinopathy - ruboxistaurin [ID382]

Status: Suspended
Expected date of issue: TBC
Referral date: November 2005
Process: STA
Topic area:
  • Endocrine, nutritional and metabolic
  • Eye
 

NICE project team

Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC
2nd appraisal committee meeting TBC
Top


 

Consultees and commentators

To be confirmed

Top


 

Project history

Date Update
25 August 2006 This topic was referred by the Department of Health and the Welsh Assembly Government as part of the Institute's 12th wave work programme.
10 January 2007 Communications manager changed
17 April 2007 The manufacturer of ruboxistaurin has advised us that they have withdrawn regulatory applications in relation to this product at this time. The Institute has therefore decided to remove this appraisal from its work programme.

As this topic has been referred to the Institute we will continue to monitor any development and will update interested parties if the situation changes.
Top


 

Key documents

This page was last updated: 28 February 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.